Literature DB >> 1576575

Clinical practice and public policy for influenza and pneumococcal vaccination of the elderly.

D S Fedson1.   

Abstract

Influenza and pneumococcal vaccines are safe, effective, and cost-effective, but they are not used widely. Organized programs for vaccine delivery can lead to substantial improvements in vaccination rates for the elderly. Adequate reimbursement by Medicare and other third-party payers needs to be supplemented by educational programs to promote influenza and pneumococcal vaccines if the opportunity vaccination presents to improve the health and well-being of elderly persons is to be fully realized.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1576575

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  9 in total

1.  Economic evaluation of influenza vaccination and economic modelling. Can results be pooled?

Authors:  T Jefferson; V Demicheli
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

Review 2.  Evaluating the impact of influenza vaccination. A North American perspective.

Authors:  D S Fedson
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

Review 3.  The cost effectiveness of pneumococcal vaccination strategies.

Authors:  C B Gable; M Botteman; G Savage; K Joy
Journal:  Pharmacoeconomics       Date:  1997-08       Impact factor: 4.981

4.  Improving surveillance of the impact of influenza and its prevention in Canada.

Authors:  D S Fedson
Journal:  Can J Infect Dis       Date:  1993-09

Review 5.  Removing barriers to vaccination use by older adults.

Authors:  J P Richardson; R J Michocki
Journal:  Drugs Aging       Date:  1994-05       Impact factor: 3.923

6.  Attitudes and behavior of health care personnel regarding influenza vaccination.

Authors:  D Ballada; L R Biasio; G Cascio; D D'Alessandro; I Donatelli; G M Fara; T Pozzi; M L Profeta; S Squarcione; D Riccò
Journal:  Eur J Epidemiol       Date:  1994-02       Impact factor: 8.082

Review 7.  Targeting pneumococcal vaccination to high-risk groups: a feasibility study in one general practice.

Authors:  A N Siriwardena
Journal:  Postgrad Med J       Date:  1999-04       Impact factor: 2.401

8.  Efficacy of influenza vaccine among elderly patients by physical activity status.

Authors:  Yuichi Hara; Akihito Hagihara; Hideyuki Ikematu; Koichi Nobutomo
Journal:  Environ Health Prev Med       Date:  2002-11       Impact factor: 3.674

9.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.